July 19, 2021 Experience Sight Sciences $276 million IPO We advised the underwriters in connection with the IPO and Nasdaq listing
July 12, 2021 Experience Novo Nordisk acquisition of Neotope Neuroscience We advised Novo Nordisk on the acquisition
June 29, 2021 Experience GH Research $184 million IPO We advised GH Research on the IPO and Nasdaq Listing
June 23, 2021 Experience ATAI Life Sciences $258.8 million IPO We advised the underwriters on the IPO and Nasdaq listing
June 23, 2021 Experience Century Therapeutics $242.7 million IPO We advised the underwriters on the IPO and Nasdaq listing
June 23, 2021 Experience Cyteir Therapeutics $133.2 million IPO We advised the underwriters on the IPO and Nasdaq listing
June 22, 2021 Experience Convey Holding Parent $186.7 million IPO We advised the underwriters on the IPO and NYSE listing
June 22, 2021 Experience Molecular Partners $64 million IPO We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
May 17, 2021 Experience Charles River Laboratories acquisition of Vigene Biosciences We are advising Charles River on the acquisition